Administration of eicosapentaenoic acid reduces cardiovascular and all-cause mortality in chronic hemodialysis patients

被引：0
|
作者：
Umemoto, N. [1 ]
Ishii, H. [2 ]
Sakakibara, T. [1 ]
Kamoi, D. [1 ]
Aoyama, T. [1 ]
Takahashi, H. [3 ]
Murohara, T. [2 ]
机构：
[1] Kyoritsu Hosp, Dept Caardiol, Nagoya, Aichi, Japan
[2] Nagoya Univ Hosp, Dept Cardiol, Nagoya, Aichi, Japan
[3] Fujita Hlth Univ, Sch Med, Dept Nephrol, Nagoya, Aichi, Japan
来源：
EUROPEAN HEART JOURNAL | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P3753
引用
收藏
页码：662 / 662
页数：1
相关论文
共 50 条
  • [1] Eicosapentaenoic Acid (EPA) Decreases the All-Cause Mortality in Hemodialysis Patients
    Inoue, Tomoko
    Okano, Kazuhiro
    Tsuruta, Yuki
    Tsuruta, Yukio
    Tsuchiya, Ken
    Akiba, Takashi
    Nitta, Kosaku
    [J]. INTERNAL MEDICINE, 2015, 54 (24) : 3133 - 3137
  • [2] EICOSAPENTAENOIC ACID (EPA) IS AN INDEPENDENT PREDICTOR OF ALL-CAUSE MORTALITY IN HEMODIALYSIS PATIENTS
    Inoue, Tomoko
    Okano, Kazuhiro
    Tsuruta, Yuki
    Tsuruta, Yukio
    Tsuchiya, Ken
    Akiba, Takashi
    Nitta, Kosaku
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 257 - 257
  • [3] Relationship between leptin and all-cause and cardiovascular mortality in chronic hemodialysis patients
    Diez, J. J.
    Bossola, M.
    Fernandez-Reyes, M. J.
    di Stasio, E.
    Tazza, L.
    Luciani, G.
    Codoceo, R.
    Iglesias, P.
    Rodriguez, A.
    Gonzalez, E.
    Selgas, R.
    [J]. NEFROLOGIA, 2011, 31 (02): : 206 - 212
  • [4] Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients
    Tetsuya Ogawa
    Hideki Ishida
    Mayuko Akamatsu
    Nami Matsuda
    Ayuko Fujiu
    Kyoko Ito
    Yoshitaka Ando
    Kosaku Nitta
    [J]. International Urology and Nephrology, 2010, 42 : 187 - 194
  • [5] Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients
    Ogawa, Tetsuya
    Ishida, Hideki
    Akamatsu, Mayuko
    Matsuda, Nami
    Fujiu, Ayuko
    Ito, Kyoko
    Ando, Yoshitaka
    Nitta, Kosaku
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (01) : 187 - 194
  • [6] Uric Acid Levels and All-Cause and Cardiovascular Mortality in the Hemodialysis Population
    Latif, Walead
    Karaboyas, Angelo
    Tong, Lin
    Winchester, James F.
    Arrington, Charlotte J.
    Pisoni, Ronald L.
    Marshall, Mark R.
    Kleophas, Werner
    Levin, Nathan W.
    Sen, Ananda
    Robinson, Bruce M.
    Saran, Rajiv
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (10): : 2470 - 2477
  • [7] Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients
    Beberashvili, Ilia
    Katkov, Anna
    Sinuani, Inna
    Azar, Ada
    Shapiro, Gregory
    Feldman, Leonid
    Gorelik, Oleg
    Stav, Kobi
    Efrati, Shai
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (04) : 254 - 265
  • [8] Plasma Cystine Levels and Cardiovascular and All-Cause Mortality in Hemodialysis Patients
    Suzuki, Shota
    Shino, Midori
    Fujikawa, Tetsuya
    Itoh, Yoko
    Ueda, Eiko
    Hashimoto, Tatsuo
    Kuji, Tadashi
    Kobayashi, Naoyuki
    Ohnishi, Toshimasa
    Hirawa, Nobuhito
    Tamura, Kouichi
    Toya, Yoshiyuki
    [J]. THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (05) : 476 - 484
  • [9] IMPACT OF POLYPHARMACY ON ALL-CAUSE MORTALITY, ALL-CAUSE HOSPITALIZATION AND CARDIOVASCULAR EVENTS IN INITIAL JAPANESE HEMODIALYSIS PATIENTS
    Toida, Tatsunori
    Toida, Reiko
    Ebihara, Shou
    Uezono, Shigehiro
    Komatsu, Hiroyuki
    Sato, Yuji
    Fujimoto, Shouichi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1831 - 1831
  • [10] Erythropoietin Resistance Index and the All-Cause Mortality of Chronic Hemodialysis Patients
    Okazaki, Masayuki
    Komatsu, Mizuki
    Kawaguchi, Hiroshi
    Tsuchiya, Ken
    Nitta, Kosaku
    [J]. BLOOD PURIFICATION, 2014, 37 (02) : 106 - 112
12345